Wijziging van de Geneesmiddelenwet ter implementatie van richtlijn 2011/62/EU om te verhinderen dat vervalste geneesmiddelen in de legale distributieketen belanden

This procedure concerns the implementation of EU Directive 2011/62/EU into Dutch law. It focuses on amending the Medicines Act to strengthen safeguards and prevent counterfeit medicines from entering the legal distribution network, ensuring patient safety and the integrity of the healthcare system. This primarily affects pharmaceutical distributors, manufacturers, and pharmacists, who must adhere to stricter controls and verification processes to identify and block falsified medical products.